Good morning, Dr.
Speaker:Seyfried.
Speaker:It's a true pleasure to
Speaker:have you on the podcast today.
Speaker:Obviously, we'll be discussing all things
Speaker:cancer in short order.
Speaker:But before we get into it, would you mind
Speaker:introducing yourself to the audience for
Speaker:those who aren't familiar
Speaker:with you and your body of work?
Speaker:Yeah, well, well, thank you, Rob.
Speaker:It's nice to be here.
Speaker:I'm a professor of
Speaker:biology at Boston College.
Speaker:I have been here for,
Speaker:well, since 1985, 40 years now.
Speaker:And before that, I was at Yale University
Speaker:in New Haven, Connecticut.
Speaker:Here at Boston College, I've taught a
Speaker:broad range of classes over the years,
Speaker:neurobiology,
Speaker:neurochemistry, neurogenetics.
Speaker:Now I teach general biology to the
Speaker:non-majors, as well as an advanced class
Speaker:in cancer metabolism.
Speaker:Cancer is a metabolic disease.
Speaker:So our background for
Speaker:biochemistry was lipid biochemistry.
Speaker:I did a lot of work
Speaker:on lipid biochemistry.
Speaker:And as far as diseases are concerned,
Speaker:lipid storage diseases, as well as
Speaker:genetic diseases, epilepsy in particular.
Speaker:And now our main focus over the last
Speaker:quarter of a century has been
Speaker:predominantly cancer.
Speaker:But we are moving into also
Speaker:other chronic diseases as well.
Speaker:So I have a kind of a
Speaker:broad-based experience.
Speaker:I have a degree in genetics and
Speaker:biochemistry, a
Speaker:master's degree in genetics.
Speaker:So those are the background educational
Speaker:experience that I've had.
Speaker:That's incredible.
Speaker:And a reason, I
Speaker:suppose, I could only dream of.
Speaker:I think one of the big issues in the
Speaker:health podcast space is creating content
Speaker:that is sort of based on actual science
Speaker:and to have someone with your background
Speaker:and credibility, I feel just, well, at
Speaker:least hopefully sort of highlight that
Speaker:we're not here just to obviously discuss
Speaker:pseudoscience today, that this is all
Speaker:sort of based in empirical data.
Speaker:Dr.
Speaker:Seafree, I know we're here to really talk
Speaker:about the metabolic theory of cancer, but
Speaker:I think it would be prudent to maybe
Speaker:start off with having a quick
Speaker:conversation about
Speaker:what cancer actually is.
Speaker:And I know it's likely a dull question,
Speaker:but I do feel it's that very few people
Speaker:actually know what the disease is.
Speaker:It's just something that
Speaker:they aim to just not get.
Speaker:I've got a few questions there, but yeah,
Speaker:maybe we could just start off with that.
Speaker:Cancer Biology 101, as it were, if you
Speaker:would just mind running
Speaker:through what cancer is.
Speaker:Well, it's actually a very, it's a
Speaker:complicated problem, but it's a very
Speaker:simple definition of what cancer is.
Speaker:It's cell division out of control,
Speaker:dysregulated cell growth.
Speaker:So people say, well, what's cancer?
Speaker:It's just a bunch of cells that are no
Speaker:longer regulated in their growth.
Speaker:Of course, the origin of
Speaker:that phenomenon is broad.
Speaker:But what is it that makes a population of
Speaker:cells in a particular organ of someone's
Speaker:body to start growing in a dysregulated
Speaker:way as opposed to normal cell division,
Speaker:which is regulated?
Speaker:In parts of our body,
Speaker:there's wear and tear.
Speaker:Cells naturally die and are replaced.
Speaker:But the replacement of dead cells is a
Speaker:very organized process.
Speaker:They grow, they divide, and they, however
Speaker:many divisions is necessary to replace
Speaker:those that are missing, is a
Speaker:well-regulated process.
Speaker:And we know now that's all
Speaker:controlled by the mitochondria.
Speaker:But an example of cell
Speaker:division under control,
Speaker:one of the, is in the gut, you have the
Speaker:crypt cells that seem to always replace
Speaker:other cells in a very regulated way.
Speaker:And in the liver, you
Speaker:have liver regeneration.
Speaker:Liver is an interesting organ because if
Speaker:you remove a lobe of the liver, the liver
Speaker:will regenerate the
Speaker:missing part of the lobe.
Speaker:And the speed of liver regenerating cells
Speaker:is just as fast as that
Speaker:of the fastest cancer.
Speaker:The only difference is that the liver
Speaker:regeneration is regulated growth, whereas
Speaker:the hepatoma of the liver, which is liver
Speaker:cancer, is dysregulated growth.
Speaker:And the biochemistry of those two
Speaker:populations is strikingly different.
Speaker:So when you ask what is cancer, it's
Speaker:dysregulated growth in a population of
Speaker:cells in someone's organ, which differs
Speaker:from regulated growth
Speaker:of cells in that organ.
Speaker:So sort of after control mitosis, you
Speaker:might say, in a nutshell.
Speaker:Yeah.
Speaker:And the question that has perplexed the
Speaker:field for decades is what regulates, what
Speaker:is responsible for
Speaker:regulated growth in the first place?
Speaker:Why would one cell know when to stop
Speaker:growing and another cell
Speaker:not know when to stop growing?
Speaker:And that all comes back to the role of
Speaker:the mitochondria and the cytoplasm.
Speaker:The mitochondrion controls calcium
Speaker:signaling within the cell.
Speaker:Nobel prizes have been awarded for people
Speaker:to learn the cyclins and
Speaker:going through the cell cycle.
Speaker:And that cell cycle is all controlled by
Speaker:calcium signaling from the mitochondria.
Speaker:So when mitochondria of the cell become
Speaker:dysfunctional in the sense of producing
Speaker:energy and that calcium gradients, they
Speaker:fall back on a fermentation metabolism,
Speaker:which is an ancient form
Speaker:of energy without oxygen.
Speaker:And the mitochondrion loses control of
Speaker:the differentiated state.
Speaker:That being anaerobic respiration.
Speaker:Yeah, anaerobic.
Speaker:You can grow cancer cells in the absence
Speaker:of oxygen or in the presence
Speaker:of cyanide and they survive.
Speaker:So which would
Speaker:normally kill normal cells.
Speaker:And that's because their energy
Speaker:metabolism is of an ancient type.
Speaker:It's the type of energy that existed on
Speaker:the planet before oxygen came into the
Speaker:atmosphere two and a
Speaker:half billion years ago.
Speaker:It was a fermentation metabolism,
Speaker:generating energy without oxygen.
Speaker:And the default state of
Speaker:cells is proliferation.
Speaker:The default energy state
Speaker:of cells is fermentation.
Speaker:So when what cancer cells are doing is
Speaker:they're simply falling back on their
Speaker:default proliferative state and their
Speaker:default energy state behaving, behaving
Speaker:much as they were of all cells that
Speaker:existed before oxygen, which was
Speaker:unbridled proliferation.
Speaker:And they would die as soon as the fuels
Speaker:that drove the flow drove the
Speaker:fermentation metabolism would dissipate
Speaker:in the micro environment
Speaker:and the cells would die.
Speaker:So it was purely an energy
Speaker:driven process without regulation.
Speaker:During the origin of life on the planet,
Speaker:archaeobacteria fused with other other
Speaker:cells to develop the mitochondria.
Speaker:And it was the mitochondria that allowed
Speaker:the division of energetic labor in the
Speaker:cells, allowing metazones to form and the
Speaker:most complex multicellular organisms that
Speaker:we have today all all due to the energy
Speaker:capacity of the mitochondria.
Speaker:And the nucleus, which everybody seems to
Speaker:have focused on, is because you could see
Speaker:it sometimes even with the naked eye,
Speaker:whereas the mitochondria for centuries
Speaker:could not be seen clearly until you had
Speaker:the electron microscope and more
Speaker:sophisticated ways of
Speaker:looking at this organelle.
Speaker:But in a nutshell, it's the mitochondria
Speaker:that controls the
Speaker:regulation of genes in the nucleus.
Speaker:So all the epigenetic stuff you hear
Speaker:about is mostly mitochondrial controlled
Speaker:mitochondria controlled.
Speaker:So the nucleus is kind of an obedient
Speaker:slave of whatever the mitochondria does
Speaker:because of that
Speaker:organelle becomes corrupted.
Speaker:The cell falls back as a and one of these
Speaker:dysregulated growths.
Speaker:So everything comes back to the origin of
Speaker:cancer as a corruption of mitochondrial
Speaker:function only in cells that can switch to
Speaker:the ancient fermentation pathways, which
Speaker:can explain why certain cells
Speaker:in our body never become tumor.
Speaker:Red blood cells can't become a tumor
Speaker:because they have no mitochondria or
Speaker:nucleus in the first place.
Speaker:Neurons of our brain
Speaker:cannot sustain fermentation.
Speaker:So you rarely, if ever,
Speaker:get cancers from neurons.
Speaker:They get from real cells.
Speaker:What about cardiac tissue?
Speaker:Cardiac tissue rarely, if ever, gets
Speaker:cancer because they cannot replace
Speaker:oxidative phosphorylation with substrate
Speaker:level phosphorylation.
Speaker:So you rarely, if ever, get cancer of
Speaker:muscle, a striate or cardiac tissue
Speaker:because they die and you can't get a
Speaker:cancer cell from a dead cell.
Speaker:So we're able to go through the body and
Speaker:look at the kinds of tissues that form
Speaker:cancer because they have the capacity to
Speaker:transition from oxidative phosphorylation
Speaker:to substrate level phosphorylation, which
Speaker:is a protracted event that
Speaker:doesn't happen overnight.
Speaker:You really have to abuse the hell out of
Speaker:your mitochondria in a
Speaker:chronic way to get cancer.
Speaker:Cancer is very hard to get.
Speaker:I know it's exploding as an epidemic, but
Speaker:we abuse the crap out of our bodies and
Speaker:that's why we're getting so much cancer.
Speaker:But it's really hard to get cancer.
Speaker:So when you say, well, how come so many
Speaker:people because they because their bodies
Speaker:have been chronically abused by a variety
Speaker:of insults, many of which
Speaker:they're not even aware of.
Speaker:But that's that's how you get cancer.
Speaker:It's a chronic disruption of oxidative
Speaker:phosphorylation coupled to a compensatory
Speaker:substrate level phosphorylation.
Speaker:And Warburg knew this a long time ago
Speaker:from the 1920s, but he only knew that it
Speaker:was a glucose driven transition from.
Speaker:But we now discovered and have I had the
Speaker:concept but not the evidence.
Speaker:But now we published the big paper
Speaker:recently that the cancer cell can ferment
Speaker:an amino acid called glutamine.
Speaker:So you get sugar and amino acid
Speaker:fermentation are driving the dysregulated
Speaker:growth of the tumor cell.
Speaker:And the field all thought it was
Speaker:glutamine respiration oxidative but it's
Speaker:not its glutamine fermentation within the
Speaker:mitochondria itself.
Speaker:So the very organelle that's supposed to
Speaker:get energy through oxidative
Speaker:phosphorylation is also producing energy
Speaker:through substrate level phosphorylation,
Speaker:which is a fermentation mechanism.
Speaker:This is what's blowing
Speaker:the doors off the field.
Speaker:You know, they never realized that the
Speaker:very organelle could also ferment.
Speaker:And that goes back to its organ its its
Speaker:origin as a bacteria itself.
Speaker:So, you know, once once you understand
Speaker:evolutionary biology, all the pieces of
Speaker:cancer fall into place
Speaker:quite, quite reasonably.
Speaker:Now, it really does.
Speaker:And I just love the fact you do brought
Speaker:up the mitochondria as being more than
Speaker:just this sort of this
Speaker:energy factory or the body.
Speaker:It's just involved in so many genetic
Speaker:processes beyond just
Speaker:helping to create ATP.
Speaker:And yeah, thanks for that.
Speaker:It really does sort of provide some
Speaker:context to what is going for
Speaker:the rest of the conversation.
Speaker:I reckon the natural follow up then
Speaker:again, this is quite a
Speaker:loose question, I suppose.
Speaker:I suppose.
Speaker:And you've really answered this too,
Speaker:to an degree.
Speaker:But I'd sort of and beyond the sort of
Speaker:the metabolic side of it, I'd love to
Speaker:sort of get your your thoughts on the
Speaker:different theories that
Speaker:are sort of driving cancer.
Speaker:Obviously, it's a complex,
Speaker:this complex aetiology there.
Speaker:And it's it would be and it shouldn't be
Speaker:viewed from this sort of reductionist
Speaker:viewpoint that there is just one
Speaker:mechanism that causes cancer.
Speaker:I know in my brief experience in academia
Speaker:that people studying these conditions can
Speaker:often get wrapped up in their own
Speaker:mechanisms and
Speaker:occasionally be blinded by research.
Speaker:Obviously, you have a
Speaker:fairly well-rounded view.
Speaker:So would you mind talking us through the
Speaker:various sort of and I hope sort of
Speaker:phrases correctly proposed triggers,
Speaker:maybe or underlying mechanisms that sort
Speaker:of lead to the development of this
Speaker:condition, sort of the genetic causes,
Speaker:the environmental risk factors, the
Speaker:immunological side of things?
Speaker:I don't know if I phrased that correctly,
Speaker:or if that makes sense.
Speaker:Yeah, well, it does.
Speaker:I mean, when you look at the history of
Speaker:of the disorder that has intrigued
Speaker:scientists, you know, for centuries,
Speaker:you know, we knew about cancer a long
Speaker:time ago, VirCal, and the 1800s people
Speaker:were studying these things.
Speaker:You know, and how does it start?
Speaker:You know, you have the emergence of
Speaker:different ideas, concepts of
Speaker:what cancer, what cancer is.
Speaker:The current view taken by all major
Speaker:research centers and academic centers is
Speaker:that it's a genetic disease.
Speaker:I know the UK thinks that the United
Speaker:States government, National Cancer
Speaker:Institute, believe that.
Speaker:I think most of the cancer institutes
Speaker:around the world, the French, the
Speaker:Germans, the English, all Western major,
Speaker:and even in China and Japan and Korea,
Speaker:you know, South America,
Speaker:they're all of the view
Speaker:that cancer is a genetic.
Speaker:It seems to be some sort of a paralytic
Speaker:mindset throughout the world.
Speaker:It's an indoctrination of brainwashing,
Speaker:if you will, of what this
Speaker:disease is supposed to be.
Speaker:But it wasn't always that way.
Speaker:You know, there was the viral cancer was
Speaker:a virus caused by viruses.
Speaker:Cancer was a metabolic disease.
Speaker:You know, cancer is a genetic disease.
Speaker:So you have to put all the views over
Speaker:time into what it is.
Speaker:And, you know, Warburg started the idea
Speaker:that it was a
Speaker:mitochondrial metabolic disease.
Speaker:But he couldn't explain certain things
Speaker:which we now can't explain.
Speaker:He didn't know about the glutamine issue,
Speaker:nor did he realize that a lot of the
Speaker:oxygen that cancer cells consume is not
Speaker:used for ATP but produces reactive oxygen
Speaker:species, ROS, which are radicals.
Speaker:And they cause, in large part, the
Speaker:mutations in the nucleus.
Speaker:So, you know, certain viruses, okay,
Speaker:well, we knew certain like papilloma
Speaker:viruses and hepatitis
Speaker:viruses and the Rous sarcoma virus.
Speaker:Peyton Rous was a Nobel Prize receiver
Speaker:for his virus particle.
Speaker:We now put all that together.
Speaker:We know all these viruses damage
Speaker:oxidative phosphorylation, chronically
Speaker:causing this transition to
Speaker:substrate-level phosphorylation.
Speaker:But it was the Watson and Crick DNA
Speaker:structural analysis that kind of sent the
Speaker:whole field off into the abyss,
Speaker:chasing stuff that we are still chasing.
Speaker:Because it became exciting to bring a
Speaker:very complicated mishi-marshi disease
Speaker:back into a molecular configuration.
Speaker:And I think that was,
Speaker:I call it physics envy.
Speaker:Biology had always been a poor stepchild
Speaker:to the pure, rational thought of the
Speaker:human mind, which was physics.
Speaker:And when the DNA structure was defined,
Speaker:and you could explain the arrangement of
Speaker:amino acids and RNAs all linked back to
Speaker:the structure of the DNA, biology was
Speaker:brought from an observational
Speaker:observational kind of a disorder or a
Speaker:field into a more quantitative way.
Speaker:And then, of course, as soon as you
Speaker:started looking at cancer cells, you
Speaker:start to see chromosomal abnormalities.
Speaker:That goes back to Theodore Bovary, who
Speaker:knew nothing about cancer.
Speaker:And he said, "I think cancer might be
Speaker:something to do with chromosomes."
Speaker:Purely speculative.
Speaker:He even said, "I'm probably wrong about
Speaker:everything," and he was.
Speaker:But the field grabbed ahold of him as the
Speaker:father of the genetic theory of cancer.
Speaker:And then, of course, you started to see
Speaker:gene mutations
Speaker:associated with certain cancers.
Speaker:And then we spent billions of dollars on
Speaker:the cancer genome projects, looking at
Speaker:every kind of a mutation.
Speaker:And then therapies, precision in medicine
Speaker:and all this developed around the genomic
Speaker:view of cancer, where we're going to have
Speaker:precision medicines,
Speaker:targeted therapies, and all this kind of
Speaker:stuff, which is where we are today.
Speaker:And all the governments and academic
Speaker:institutions are giving away millions of
Speaker:dollars in grants to people trying to
Speaker:hunt down genes that could be responsible
Speaker:for the dysregulated cell growth.
Speaker:So it comes back.
Speaker:We know cancer is a
Speaker:dysregulated cell growth.
Speaker:What's causing that?
Speaker:Well, according to the somatic mutation
Speaker:theory, which is the dominant theory
Speaker:today, it's mutations
Speaker:that are causing that.
Speaker:But I've clearly shown that those
Speaker:mutations are largely irrelevant.
Speaker:With our research, they can't attack it
Speaker:because the evidence is too strong.
Speaker:So when you have evidence that's
Speaker:overwhelmingly strong and it's not
Speaker:consistent with your general
Speaker:theory, then you ignore it.
Speaker:But you're only going
Speaker:to ignore it for so long.
Speaker:So when you develop a theory,
Speaker:theories are supported by a massive
Speaker:amounts of evidence.
Speaker:The somatic mutation theory was very,
Speaker:very strong because you found almost all
Speaker:cancers with somatic mutations.
Speaker:And these somatic mutations, some of them
Speaker:were linked to the cell cycle, which you
Speaker:could then link a mutation in the genome
Speaker:to something that would lead to
Speaker:dysregulation or
Speaker:dysfunction of the cell cycle.
Speaker:And that made a lot of sense.
Speaker:So people grabbed onto that.
Speaker:And because it was so molecular and so
Speaker:quantitative and approachable by really
Speaker:sophisticated technologies which have
Speaker:developed around cancer, like all these
Speaker:sequencing, unbelievable AI now,
Speaker:artificial intelligence helping analysis
Speaker:of sequencing, and all of the different
Speaker:kinds and types of mutations that were
Speaker:found in cancer cells.
Speaker:I mean, it was an explosion of molecular
Speaker:biology associated with cancer.
Speaker:So that was very
Speaker:attractive to a lot of people.
Speaker:But then having done work in Meyerle lab
Speaker:and seeing research that was far more
Speaker:consistent with what Otto Wirberg said
Speaker:than with the somatic mutation theory, I
Speaker:began to look at this.
Speaker:But getting back to theories, I like to
Speaker:compare what's happening today with the
Speaker:mitochondrial metabolic theory replacing
Speaker:the somatic mutation theory because it really takes a lot of
Speaker:evidence to replace a theory.
Speaker:Einstein's theory of relativity could
Speaker:still be replaced, but has not yet been.
Speaker:And there are physicists that are
Speaker:constantly trying to show where Einstein
Speaker:was wrong, and they believe
Speaker:they might, but they haven't.
Speaker:Darwin's theory of evolution has been
Speaker:challenged many times, but it has not
Speaker:been overthrown because the data that
Speaker:support it are stronger than the data that don't support it.
Speaker:And then you have the geocentric
Speaker:heliocentric theory of the solar system,
Speaker:where for 1800 years, people thought that
Speaker:the Earth was the
Speaker:center of the solar system.
Speaker:And we developed equants, deference, and
Speaker:epicycles to try to predict
Speaker:the positions of the planets.
Speaker:And Copernicus just
Speaker:replaced the Earth with the sun.
Speaker:And all of a sudden, a lot of stuff was
Speaker:far less complicated and more understandable.
Speaker:So the heliocentric theory replaced the
Speaker:geocentric theory, opened up a scientific
Speaker:revolution during the Middle Ages,
Speaker:the Renaissance period.
Speaker:What we're having today is that
Speaker:mitochondrial metabolic theory is
Speaker:overturning the somatic mutation theory.
Speaker:And the consequences are going to be
Speaker:every bit as phenomenal as what happened
Speaker:during the Copernican revolution.
Speaker:So we look at
Speaker:evidence to support a theory.
Speaker:If cancer is a disease of somatic
Speaker:mutations, which is the current dogma,
Speaker:irrefutable truth, the silent assumption,
Speaker:cancer is a genetic disease.
Speaker:Well, now with deep sequencing and deeper
Speaker:analysis, we find some cancer cells that
Speaker:don't have any mutations, yet they're
Speaker:growing out of control.
Speaker:So when I looked at those, there's not many papers that I've looked at.
Speaker:So when I looked at those, there's not
Speaker:many papers, but there are
Speaker:some very clear findings.
Speaker:And then when I say, what do the
Speaker:investigators who believe that cancer is
Speaker:a genetic disease say about cancer cells
Speaker:that don't have mutations or
Speaker:they can't find any mutations?
Speaker:And they don't say anything.
Speaker:So when I went back and looked at their
Speaker:explanation, they
Speaker:didn't even, they ignored it.
Speaker:They didn't even talk about the cancer
Speaker:cells that had no mutations.
Speaker:They just seemed to focus on all the
Speaker:cancer cells that had mutations.
Speaker:And I said, you got a glaring
Speaker:inconsistency in your theory, staring you
Speaker:in the face and you did not address it.
Speaker:What the hell is going on with that?
Speaker:Then, of course, they realized that
Speaker:there's so many hundreds of thousands of
Speaker:mutations in some of these tumor cells.
Speaker:They all can't be drivers
Speaker:of dysregulated cell growth.
Speaker:So then the field decided to reclassify
Speaker:some of the mutations as
Speaker:passenger genes and driver genes.
Speaker:So we then moved into the driver gene
Speaker:mentality, which lasted several decades.
Speaker:Where only some of these many mutations
Speaker:are truly responsible for dysregulated
Speaker:cell growth and we
Speaker:redefined them as called drivers.
Speaker:And that got, that generated a lot of
Speaker:excitement since the 19, early 1980s, I
Speaker:guess, middle eighties, driver genes,
Speaker:driver, oh, the driver genes.
Speaker:So now with deep sequencing and more
Speaker:sophisticated technologies, we're finding
Speaker:all kinds of mutations in
Speaker:driver genes in our normal tissues.
Speaker:Like you and me.
Speaker:I mean, we got all kinds of mutations in
Speaker:P53 and MIC and RAS and all these kinds
Speaker:of genes that are in our normal tissues
Speaker:and are not dysregulated in growth.
Speaker:How do you explain that?
Speaker:That's inconsistent with
Speaker:your somatic mutation theory.
Speaker:Are there any real sort of polygenic risk
Speaker:goals maybe that sort of have been
Speaker:identified in respect to this?
Speaker:Well, the nuclear mitochondrial transfer
Speaker:experiments throw, that's the real nail
Speaker:in the coffin for the whole thing.
Speaker:Because what was done on a variety of
Speaker:different types of cancers is that the
Speaker:nucleus of the tumor cell is now placed
Speaker:in the cytoplasm of a
Speaker:non-neoplastic cell.
Speaker:And invariably you get regulated growth,
Speaker:despite the continued presence of
Speaker:whatever kind of genetic abnormality
Speaker:might have been in that nucleus.
Speaker:Whether it was polygenic, whether it was
Speaker:chromosomal, whether it was point
Speaker:mutations, frame shift mutation, didn't
Speaker:make any difference.
Speaker:When that cancer nucleus was placed into
Speaker:the cytoplasm of a non-cancerous cell,
Speaker:that new cell no longer
Speaker:had dysregulated cell growth.
Speaker:That's quite interesting.
Speaker:And that's been done repeatedly.
Speaker:And in vivo and in vitro.
Speaker:So in all kinds of experimental systems,
Speaker:meaning that normal cytoplasm
Speaker:suppresses neoplastic growth.
Speaker:On the other hand, if the nucleus of a
Speaker:normal cell is now placed in the
Speaker:cytoplasm of a tumor cell, you've got
Speaker:dysregulated growth,
Speaker:which is completely the opposite of what
Speaker:you would have expected on
Speaker:the somatic mutation theory.
Speaker:So when you have the opportunity to sit
Speaker:down and carefully evaluate all of the
Speaker:evidence from the nuclear mitochondrial
Speaker:transfer experiments, also, if you have a
Speaker:raging tumor cell and you replace the
Speaker:mitochondria with normal mitochondria,
Speaker:just put normal mitochondria, you get
Speaker:complete downregulation of this
Speaker:dysregulated growth.
Speaker:You can convert a raging tumor cell into
Speaker:an indolent tumor cell by putting normal
Speaker:mitochondria back in the cytoplasm,
Speaker:mitochondrial medicine type.
Speaker:I was about to say, I'm getting ahead of
Speaker:my curve and I'm going to shoot myself in
Speaker:the foot by asking this question now, but
Speaker:just with regards to that, then, is there
Speaker:any thought to the idea that
Speaker:mitochondrial transplants could be a
Speaker:potential therapy in that regard?
Speaker:Absolutely.
Speaker:But that's the future.
Speaker:It's not here yet, because we have to
Speaker:make sure that the mitochondria that are
Speaker:transplanted are normal in numbers,
Speaker:structure, and function.
Speaker:And during the very process of
Speaker:manipulating these
Speaker:mitochondria, you can also damage them.
Speaker:And you have to know how to do that.
Speaker:So mitochondrial medicine
Speaker:is going to be the future.
Speaker:But where the technology
Speaker:to do that is not here yet.
Speaker:So our approach to managing cancer is
Speaker:killing the tumor cells while not harming
Speaker:the rest of the body and then allowing
Speaker:people to live far longer with a higher
Speaker:quality of life, while mitochondrial
Speaker:medicine is under development.
Speaker:That's the thing.
Speaker:It's very interesting, because when you
Speaker:have dysregulated cell growth in cancer,
Speaker:they're fermenting like crazy.
Speaker:And the oncogenes, which have generated
Speaker:tremendous interest, we have shown, and
Speaker:others, HIF1, alpha, MIC, and these
Speaker:things, they are there.
Speaker:And they are facilitators of opening the
Speaker:floodgates for fermentation
Speaker:fuels to get into the cell.
Speaker:And when you put new mitochondria into
Speaker:the cell, the oncogenes turn off.
Speaker:You don't need them anymore.
Speaker:Why are you going to
Speaker:ferment when I can respire?
Speaker:So the oncogenes are no longer needed.
Speaker:And normal mitochondrial respiration turn
Speaker:off oncogene expression.
Speaker:So you shut down the glycolysis and the
Speaker:glutaminolysis pathways, because you
Speaker:don't need glucose and glutamine.
Speaker:You can respire.
Speaker:Everything makes perfect sense.
Speaker:And the data show that.
Speaker:So where did all the mutations come from?
Speaker:They came from the biology of inefficient
Speaker:oxidative phosphorylation, throwing out
Speaker:reactive oxygen species, which is the
Speaker:superoxide and the anion, the OH radical,
Speaker:which are carcinogenic and mutagenic.
Speaker:And they come out of the dysfunctional
Speaker:mitochondria, creating an escalating
Speaker:situation of biological chaos.
Speaker:So what we're seeing, or what the field
Speaker:is mostly focusing on, is downstream
Speaker:epiphenomena of the damage to
Speaker:mitochondria and all the
Speaker:sequelae that follow that.
Speaker:It's really amazing to me.
Speaker:I just can't figure out how the field
Speaker:doesn't understand this.
Speaker:I try to, I don't know, maybe
Speaker:I have to write it in crayon.
Speaker:Sometimes you just have to do that.
Speaker:You have to take the back of a neck and
Speaker:smash the guy's face into
Speaker:the evidence to let him see it.
Speaker:But the interesting thing is that you see
Speaker:all these clear evidence that you can
Speaker:manage this disease quite effectively by
Speaker:just depriving the cell of the two
Speaker:fermentable fuels that it needs and then
Speaker:transitioning the whole body over the
Speaker:fuels that the tumor cells can't use.
Speaker:So intrinsically,
Speaker:people say, oh, cancer cells are so tough
Speaker:and hardy, and they're so versatile.
Speaker:That's total crap.
Speaker:How do you explain a cell with a nucleus
Speaker:blown to hell with all these mutations?
Speaker:And you're going to
Speaker:have that cell behave more
Speaker:transitional and more flexible than the
Speaker:cells in our body that evolved over
Speaker:millions of years to adjust their
Speaker:metabolism to the situation.
Speaker:And the cancer cell can do this with a
Speaker:nucleus that's blown to hell.
Speaker:Makes no sense in evolutionary biology.
Speaker:People don't
Speaker:understand evolutionary biology.
Speaker:The way you understand cancer and many
Speaker:other diseases, you must understand
Speaker:evolutionary biology.
Speaker:And if you don't do that,
Speaker:you're going to be in the dark.
Speaker:You're going to be in the dark.
Speaker:And that explains a lot of the stuff that
Speaker:we have in medicine today, because people
Speaker:don't understand evolutionary biology.
Speaker:They remain in the dark.
Speaker:And as long as you remain in the dark,
Speaker:you ain't moving forward.
Speaker:So here's what they say.
Speaker:Oh, cancer cells are tough to kill
Speaker:because we're throwing everything at
Speaker:radiation and chemo and immunotherapies.
Speaker:And those damn cancer cells can survive.
Speaker:They're protecting themselves with the
Speaker:waste products of
Speaker:fermentation metabolism.
Speaker:Everybody knows.
Speaker:They say, oh, the cancer environment is
Speaker:so acidified, it protects them from the
Speaker:therapies that we have.
Speaker:Where does the acidification come from?
Speaker:The waste products of glucose and
Speaker:glutamine fermentation.
Speaker:If you take away glucose and glutamine,
Speaker:you remove the acidification of the micro
Speaker:environment, making the tumor cells
Speaker:extremely vulnerable to small doses of
Speaker:radiation, chemo, and
Speaker:these other procedures.
Speaker:How is that not understood by guys that
Speaker:are supposed to be smart?
Speaker:Don't you understand why the damn tumor
Speaker:cells are not dying from
Speaker:what you're throwing at them?
Speaker:Because they're fermenting.
Speaker:If they ferment, you take
Speaker:away the fermentable fuels.
Speaker:Oh, that can't be right.
Speaker:It's too simple.
Speaker:Yeah.
Speaker:And it works.
Speaker:And it is right.
Speaker:Get over it.
Speaker:You want to live longer, you take away
Speaker:the fermentable fuels, and then you give
Speaker:them fatty acids and ketones, and the
Speaker:cancer cell can't because
Speaker:you need a good mitochondria.
Speaker:Fatty acids and ketone bodies cannot be
Speaker:used as a fuel by cancer cells because
Speaker:the mitochondria are inefficient.
Speaker:Fatty acids and ketone bodies can be used
Speaker:by most of our normal cells because we
Speaker:have good
Speaker:mitochondria, healthy mitochondria.
Speaker:So we lower the blood sugar, elevate the
Speaker:ketones, and then come in and target the
Speaker:glutamine pathways strategically in an
Speaker:approach that we developed, the press
Speaker:pulse therapeutic strategy.
Speaker:Glucose is a non-essential metabolite.
Speaker:Glucose is a non-essential metabolite.
Speaker:We can live with very, very minimal
Speaker:levels of glucose just to keep our
Speaker:erythrocytes moving oxygen
Speaker:and CO2 through the body.
Speaker:It takes tiny amounts of glucose.
Speaker:But the majority of muscles and brain can
Speaker:all transition over to ketone bodies.
Speaker:Tumor cells cannot.
Speaker:We tested them.
Speaker:We interrogated these cells.
Speaker:Tumor cells collect huge droplets of
Speaker:fatty acids in the cytoplasm because they
Speaker:cannot use the fatty acids.
Speaker:If you force the tumor cell to use the
Speaker:fatty acids, it develops reactive oxygen
Speaker:species and explodes and dies.
Speaker:So that's why they store the fatty acids
Speaker:in the cytoplasm because if they try to
Speaker:use them, they're going to kill them.
Speaker:So this is simply a protective mechanism.
Speaker:I can't tell you how many people are
Speaker:writing papers saying tumor cells love
Speaker:fatty acids because they store them in
Speaker:the cytoplasm because
Speaker:they need them for fuel.
Speaker:Yeah, well, try to goose the cell to use
Speaker:the fatty acids and all
Speaker:of a sudden the cell dies.
Speaker:Try to grow your cells, your cancer cells
Speaker:in the absence of glucose and glutamine
Speaker:in the presence of fatty
Speaker:acids in ketone bodies.
Speaker:With no glucose, no
Speaker:fermentable fuels, they die.
Speaker:So it becomes very
Speaker:clear how to manage cancer.
Speaker:So we're aware of this.
Speaker:Unfortunately, the field still has to
Speaker:come to grips with this
Speaker:and I think they slowly are,
Speaker:but it takes time, unfortunately.
Speaker:Yeah, I know.
Speaker:I think we could
Speaker:probably stop the podcast there.
Speaker:That was incredible.
Speaker:Thank you.
Speaker:I'm definitely going to have
Speaker:to re-listen to a bunch of that.
Speaker:Well, not only listen, not only re-listen
Speaker:to it, read the damn
Speaker:papers that we published.
Speaker:I go into great biochemical details.
Speaker:I have the evidence put out in those
Speaker:papers that we published
Speaker:and they're open access.
Speaker:So everybody can read them.
Speaker:Anybody with a few functional brain cells
Speaker:can sit down and read these papers and
Speaker:make their own decision as to what they
Speaker:think in light of that.
Speaker:I do a compare and contrast the theories.
Speaker:I do the evidence supporting the
Speaker:different theories and you tell me what
Speaker:you think is happening.
Speaker:And I learned there's very few people
Speaker:that actually understand or not
Speaker:understand that who read
Speaker:actually read the literature.
Speaker:They all wait and they only do what other
Speaker:people are doing and they ask other
Speaker:people what they think.
Speaker:And if the person
Speaker:says, "Oh, no, it can't be.
Speaker:Okay, then I believe it can't be."
Speaker:Why don't you use your own brain cells
Speaker:and analyze the data for yourself?
Speaker:That's one of the great things about
Speaker:humans is we have a rational mind.
Speaker:That's what we were gifted with.
Speaker:But I'll tell you, dogmatic views,
Speaker:political, religion, all that takes away
Speaker:from rational thinking.
Speaker:And when you lose your ability to sit and
Speaker:rationalize, then you
Speaker:lose a part of your humanity.
Speaker:And what we're seeing here, the reason
Speaker:why there's a delay in the movement from
Speaker:the somatic mutation theory to the
Speaker:mitochondrial metabolic theory, which
Speaker:will prevent and manage
Speaker:diseases dramatically.
Speaker:We're going to drop cancer death rates
Speaker:like there's no tomorrow.
Speaker:We're going to keep people alive because
Speaker:we understand the science
Speaker:supporting what we're saying.
Speaker:And then once people start looking at it
Speaker:and seeing that we are essentially
Speaker:correct, not on all the minutia, we can
Speaker:always work out minutia later on.
Speaker:But the bottom line is how long can I
Speaker:keep somebody with a
Speaker:stage four tumor alive?
Speaker:Oh, he's got three months to live.
Speaker:Are you kidding me?
Speaker:We've got people that were given those
Speaker:days, they're still alive five and six
Speaker:years later because they've transitioned
Speaker:their body over to nutritional ketosis
Speaker:and came in with certain low dose
Speaker:medications to kill off the tumor cells.
Speaker:So I know it's going to work because I've
Speaker:seen enough preclinical studies and human
Speaker:studies, small trials, to know this will
Speaker:work and keeps people alive.
Speaker:Unfortunately, you go to the top
Speaker:hospitals and they tell you,
Speaker:oh, no, you got to have this.
Speaker:Did you ever hear the
Speaker:cancer is a med about?
Speaker:No, I never heard of it.
Speaker:Eat sugar, eat all the
Speaker:high carbohydrate diets.
Speaker:Why?
Speaker:Oh, because you're losing weight.
Speaker:Why am I losing weight?
Speaker:Well, you have cancer and
Speaker:we just try to poison you.
Speaker:Anybody who's poisoned loses weight.
Speaker:So you get nausea and
Speaker:vomiting, diarrhea, fatigue.
Speaker:Why are you doing that?
Speaker:Well, we use the toxic poison on you.
Speaker:Why are you doing that?
Speaker:Well, we're trying to
Speaker:kill your tumor cells.
Speaker:I went bald.
Speaker:Why?
Speaker:Why you go bald?
Speaker:I lost all my hair.
Speaker:Oh, did you have tumor cells growing in
Speaker:your hair follicles?
Speaker:No, they just happened to die.
Speaker:You're trying to kill tumor cells, not
Speaker:kill your hair or blow out your gut.
Speaker:That tells you that those are the
Speaker:procedures of people who lack knowledge.
Speaker:What we're seeing is the result of
Speaker:massive lack of knowledge on the
Speaker:biochemistry and biology of the very
Speaker:disease that people are working with.
Speaker:And we're using medieval therapies that
Speaker:are torturing people.
Speaker:I think people during the Spanish
Speaker:Inquisition would be very impressed with
Speaker:how we're torturing cancer
Speaker:patients in these hospitals.
Speaker:They could say, "Well, we can learn
Speaker:something from you guys.
Speaker:Where do I get Red Devil Doxorubicin?
Speaker:We could give that to a heretic."
Speaker:It's terrible for me
Speaker:to say stuff like this.
Speaker:But when you see 1700 people a day in the
Speaker:United States dying from cancer, 70
Speaker:people an hour, and you see cancer
Speaker:getting worse and worse around the world,
Speaker:I mean, grab somebody by the throat and
Speaker:say, "What the hell are we doing?
Speaker:Why are we allowing this to happen?"
Speaker:Because of a failed theory.
Speaker:That's what it is, a theory that's no
Speaker:longer supported by the evidence.
Speaker:And you guys keep treating people based
Speaker:on an incorrect theory,
Speaker:and the outcome is abysmal.
Speaker:Yeah.
Speaker:What did Einstein say?
Speaker:Insanity is doing the same thing over and
Speaker:over again and expecting a different
Speaker:result, something to that extent.
Speaker:Yes.
Speaker:Well, why are they doing?
Speaker:Don't they know what Einstein said?
Speaker:Did they not hear what Einstein said?
Speaker:And there's another issue of morality,
Speaker:which is even a worse issue.
Speaker:You don't like to be referred to as an
Speaker:immoral person, but when you're taking
Speaker:drugs that are not based on the correct
Speaker:theory and treating people with them and
Speaker:knowing that they won't work,
Speaker:and that's immoral.
Speaker:And the other part of this is that many
Speaker:of those drugs are very, very expensive.
Speaker:And what happens, they not only cause
Speaker:physical toxicity, they
Speaker:cause financial toxicity.
Speaker:Many people, their marriage is dissolved,
Speaker:they commit suicide, the cost is passed
Speaker:on to the surviving relatives.
Speaker:And for folks that are not well off, a
Speaker:$20,000 bill, even though they covered
Speaker:80% of the 100,000,
Speaker:20,000 can cripple a family.
Speaker:With limited means.
Speaker:This is immoral.
Speaker:The whole cancer
Speaker:industry is an immoral industry.
Speaker:They're allowing people to suffer and die
Speaker:based on an incorrect theory.
Speaker:And they're allowing
Speaker:physical and financial toxicity.
Speaker:These are immoral acts.
Speaker:And we have a strategy that can
Speaker:absolutely reduce the deaths of cancer,
Speaker:keep people alive with a higher quality
Speaker:of life, and it's not being
Speaker:done anywhere on the planet.
Speaker:Now you tell me what's wrong with that.
Speaker:Yeah, I'm not even going to try and sort
Speaker:of answer that
Speaker:question just at this point.
Speaker:Dr.
Speaker:Seifried, again, that
Speaker:was an amazing answer.
Speaker:Thank you.
Speaker:I'd just like to take a step back quickly
Speaker:and discuss, have a quick discussion
Speaker:about your thoughts on testing.
Speaker:Now, the way I see testing, testing is
Speaker:generally done quite acutely when
Speaker:somebody presents with
Speaker:a disease in this case.
Speaker:You'll obviously get a physical exam
Speaker:done, some sort of imaging, probably some
Speaker:sort of biopsy as well, some blood tests
Speaker:looking at various biomarkers, et cetera.
Speaker:But in no way is this
Speaker:sort of testing preventative.
Speaker:It generally is only treated and dealt
Speaker:with when the issues arise.
Speaker:Now, obviously, there are various
Speaker:technologies that are starting to sort of
Speaker:come up to things like liquid biopsies.
Speaker:Maybe you could elucidate on that
Speaker:slightly and these full-body MRIs, which
Speaker:are obviously somewhat controversial in
Speaker:the sense that they may or
Speaker:may not pick up incident lomas.
Speaker:The idea of finding an issue that may not
Speaker:be an issue that then requires further
Speaker:investigation that then may or may not
Speaker:actually turn into an issue.
Speaker:What's your stance on
Speaker:early detection as a whole?
Speaker:Do you think it's something we should be
Speaker:exploring more beyond just the basic get
Speaker:your colonoscopy done
Speaker:when you hit 40 plus?
Speaker:Or does the whole thing again about
Speaker:incident lomas and treating cancer from
Speaker:that perspective and, excuse me, treating
Speaker:and scanning for cancer from that
Speaker:perspective generally make
Speaker:it a bit of a mute point?
Speaker:Yeah, well, you have a couple
Speaker:of things here to break down.
Speaker:The diagnostics, I'm in favor of
Speaker:non-invasive diagnostic approaches.
Speaker:If we have a liquid biopsy that's 95%
Speaker:accurate in determining whether or not
Speaker:you have a neoplastic growth somewhere in
Speaker:your body, I'm all for that.
Speaker:And then non-invasive imaging, whether
Speaker:it's a PET scan, MRI, CAT scan, or one of
Speaker:these kinds of things, I'm not in favor
Speaker:of biopsy because I have seen so many
Speaker:papers published in the scientific
Speaker:literature showing that when you stab a
Speaker:cancer, you run the risk of causing
Speaker:metastasis, metastasis where the spread
Speaker:of the tumor, the cells can spread around
Speaker:your body making what was formerly a
Speaker:localized problem, a systemic problem.
Speaker:So I'm in favor of four diagnostics,
Speaker:colonoscopies and and breast
Speaker:things and stuff like this.
Speaker:Those are, you know, I
Speaker:don't know what to say
Speaker:about that.
Speaker:I know there's a lot of
Speaker:controversy about that.
Speaker:And most people who develop cancer have
Speaker:certain physical signs in
Speaker:their body that something is wrong.
Speaker:Like you said, a lump,
Speaker:a wound that doesn't heal blood that
Speaker:continues to come from some location.
Speaker:You know, those can be then liquid biopsy
Speaker:to see if there's a real linkage to some
Speaker:neoplasia, a scanning of the body or
Speaker:something along these lines.
Speaker:And then once you would make a diagnosis
Speaker:without a biopsy, you see a lump.
Speaker:Okay, let's launch into metabolic therapy
Speaker:and see if we can shrink the lump
Speaker:naturally with diet drug combinations,
Speaker:non-toxic drugs and diets that we've
Speaker:developed here at BC.
Speaker:And if you shrink the lump and it goes
Speaker:away, and the imaging analysis and the
Speaker:liquid biopsy data, what happened?
Speaker:Where did it go?
Speaker:I don't see any of the
Speaker:markers that were there previously.
Speaker:That's great.
Speaker:And if it doesn't go away completely,
Speaker:you might have shrunken it down and make
Speaker:it much smaller, in which case a surgical
Speaker:procedure or a dose of radiation at a
Speaker:very defined spot could
Speaker:be potentially curative.
Speaker:So there's a lot of ways to diagnose and
Speaker:treat cancer in the early stages
Speaker:different than what we're doing today.
Speaker:You know, we're doing too
Speaker:radical on this whole thing.
Speaker:You know, you see a lump in the rip the
Speaker:person's breasts off
Speaker:or something like this.
Speaker:You know, I don't know what to say about
Speaker:colonoscopies or breast exam exams.
Speaker:Breast cancer rises every
Speaker:year in females in this country.
Speaker:Colorectal cancer is on the rise.
Speaker:So I don't know what's going on.
Speaker:All the major cancers seem to be, many of
Speaker:the major cancers seem to be on the rise.
Speaker:It's happening in
Speaker:younger and younger people.
Speaker:Yeah, if you're to speculate, do you
Speaker:think that is an environmental issue,
Speaker:just sort of maybe excess sort of
Speaker:zenoestrogens in the environment that are
Speaker:particularly just from a breast cancer
Speaker:perspective, maybe
Speaker:triggering these issues?
Speaker:Or is that a bit productionist again?
Speaker:I think most of it is environmental.
Speaker:I mean, there are some people who have
Speaker:genetic predispositions to
Speaker:insults from the environment.
Speaker:You have to realize
Speaker:that cancer is a disease.
Speaker:In fact, not only cancer, most of the
Speaker:chronic diseases that we are dealing
Speaker:with, which is dementia, type 2 diabetes,
Speaker:obesity, hypertension, high blood
Speaker:pressure, a lot of neuropsychiatric
Speaker:problems, are all the result of
Speaker:mitochondrial dysfunction in one way or
Speaker:another, caused by the diet lifestyle
Speaker:that we're all under.
Speaker:And we know this pretty much because
Speaker:Paleolithic men would not have had any of
Speaker:these kinds of conditions.
Speaker:They died predominantly
Speaker:from infections and injuries.
Speaker:They did not have orthopedic surgeons to
Speaker:repair a broken knee from
Speaker:some guy gored by a buffalo.
Speaker:And how do we know that?
Speaker:Because people say, "Well, you weren't
Speaker:there during Paleolithic
Speaker:period 500,000 years ago."
Speaker:But we have people on the planet who
Speaker:still live, according
Speaker:to traditional ways.
Speaker:And these folks also didn't have cancer
Speaker:or a lot of the chronic
Speaker:diseases that we have today.
Speaker:How do we know that?
Speaker:Because Albert Schweitzer and a number of
Speaker:other physicians and humanitarians were
Speaker:investigating these primitive tribes.
Speaker:And they said, "Wow, they're remarkably
Speaker:different from those that live in the
Speaker:United States and England."
Speaker:So they were not obese.
Speaker:They didn't have any chronic diseases.
Speaker:They had bacterial infections, parasites,
Speaker:and things like this.
Speaker:So what's the difference between the
Speaker:Western diet lifestyle and the
Speaker:Paleolithic diet and lifestyle?
Speaker:And predominantly, it's the availability
Speaker:of highly processed
Speaker:carbohydrates in our diets.
Speaker:A Paleolithic man never had highly
Speaker:processed carbohydrates in his diet.
Speaker:We did not evolve to evolve in an
Speaker:environment with highly processed carbs.
Speaker:But highly processed carbohydrates, are
Speaker:you talking, obviously,
Speaker:and my evolution biology is definitely
Speaker:not my strong point, but I assume you
Speaker:mean very high GI carbohydrates, things
Speaker:like your processed sugars, honeys, etc.,
Speaker:opposed to things like root vegetables,
Speaker:things that are potentially
Speaker:lower on the glycemic scale.
Speaker:That maybe wouldn't...
Speaker:Yes, predominantly.
Speaker:Things that can
Speaker:remain edible in a package.
Speaker:Like I have a Twinkie here.
Speaker:This Twinkie is 10 years
Speaker:old, and it looks edible.
Speaker:And a mouse, it's 10 years old, and a
Speaker:mouse ate it, broke in and ate one of
Speaker:these two years ago.
Speaker:And he didn't complain.
Speaker:And there are people that are hungry that
Speaker:would eat 10 year old Twinkie.
Speaker:This is a synthetic thing made from all
Speaker:chemicals and sugars.
Speaker:This kind of stuff will kill you.
Speaker:Yet we eat large amounts of it.
Speaker:Not only that, we deep fry it and put
Speaker:powdered sugar and
Speaker:chocolate syrup on it, damn thing.
Speaker:You should go to Scotland.
Speaker:That's the Shon's Act breakfast.
Speaker:Yeah, right.
Speaker:So then we wonder why we got cancer and
Speaker:high blood pressure and hypertension and
Speaker:neuropsychiatric problems.
Speaker:And the lack of exercise is unbelievable.
Speaker:Paleo, you know how hard it is to track
Speaker:down and kill a big animal?
Speaker:It's not easy.
Speaker:You have to have well runners.
Speaker:You have to have strong guys to track
Speaker:down and kill these buffalo.
Speaker:And you have to kill a mammoth, a woolly
Speaker:mammoth, and these kinds of big animals
Speaker:that lived in paleolithic times.
Speaker:And that was a lot of energy to kill, not
Speaker:only to kill the big thing,
Speaker:but to chop it up and eat it.
Speaker:You know, they'd go for the bone marrow
Speaker:as a fuel source that
Speaker:was very rich in nutrients.
Speaker:We're sitting in traffic today.
Speaker:We're sitting in front of computers.
Speaker:We don't nearly have the amount of energy
Speaker:that was expended
Speaker:during paleolithic times.
Speaker:We're eating highly
Speaker:processed carbs, bad food.
Speaker:We have bad sleep.
Speaker:We have emotional stress.
Speaker:We have all of these things that impact
Speaker:negatively the number structure and
Speaker:function of mitochondria in our cells.
Speaker:It is not surprising that we have all of
Speaker:the chronic diseases in cancer that we
Speaker:are currently suffering with
Speaker:in modern Western societies.
Speaker:It's absolutely understandable in terms
Speaker:of our evolutionary biology.
Speaker:We are still paleolithic man
Speaker:biologically, but living in a modern,
Speaker:industrialized society where all of the
Speaker:desires that we would have had in
Speaker:paleolithic time are now at our
Speaker:fingertips in any supermarket.
Speaker:We don't have to go out
Speaker:and hunt down animals.
Speaker:Everything is prepared, packaged, and
Speaker:ready for us to eat right away.
Speaker:We don't have to expend a lot of energy
Speaker:to cook it up, kill it,
Speaker:and cook it every night.
Speaker:It's preserved, well preserved, so we can
Speaker:store it for a long
Speaker:period of time and eat it.
Speaker:Eventually, it beats the hell out of your
Speaker:mitochondria in your body.
Speaker:Some people, you get obesity, type 2
Speaker:diabetes, hypertension, high blood
Speaker:pressure, macular
Speaker:degeneration, dementia, cancer.
Speaker:Every one of those diseases, disorders,
Speaker:is the result of mitochondrial
Speaker:dysfunction in one way or another.
Speaker:Some cells up and die become
Speaker:dysfunctional, not becoming cancer.
Speaker:Some cells that have the capacity to
Speaker:switch from oxfoss to substrate-level
Speaker:phosphorylation become cancerous.
Speaker:We can link all of the major chronic
Speaker:diseases, including cancer, back to
Speaker:mitochondrial dysfunction, which then
Speaker:begs the question, well,
Speaker:how do you prevent cancer?
Speaker:And you keep your mitochondria healthy.
Speaker:It's extremely difficult to get cancer if
Speaker:you're mitochondria healthy.
Speaker:Well, how do I keep my
Speaker:mitochondrial healthy?
Speaker:Do a lot of exercise, stress management,
Speaker:avoid highly processed carbohydrate
Speaker:foods, try to get good sleep.
Speaker:Do all the things that keep mitochondria
Speaker:healthy, and you don't get dementia, you
Speaker:don't get cardiovascular
Speaker:disease, you don't become obese,
Speaker:you don't get cancer.
Speaker:You significantly reduce the risk for
Speaker:cancer and all these chronic diseases by
Speaker:keeping your mitochondria healthy.
Speaker:It's very interesting.
Speaker:In the United States,
Speaker:the NCI National Cancer Institute says,
Speaker:"We reduce cancer by 33% over the last
Speaker:several decades, mainly because we had
Speaker:the anti-smoking campaign of the 1990s.
Speaker:And if we all continue to smoke like
Speaker:crazy, like we were in the 1990s, we
Speaker:would have 33% more dead cancer patients
Speaker:today than we actually have."
Speaker:So clearly, the major drop in cancer
Speaker:deaths came from the
Speaker:elimination of a provocative
Speaker:behavioral situation, which was smoking.
Speaker:So why?
Speaker:Because our mitochondria are healthier
Speaker:when you don't smoke.
Speaker:And everything comes back to the health
Speaker:and vitality of the mitochondria.
Speaker:Do we want to go back and become, again,
Speaker:live in a cave like Paleolithic Man?
Speaker:No.
Speaker:No,
Speaker:but finding that happy middle ground.
Speaker:Yes.
Speaker:But now we have an awareness.
Speaker:And not only that, we develop the glucose
Speaker:ketone index calculator.
Speaker:My next question was
Speaker:going to be exactly that.
Speaker:Which is now going to be the tool to
Speaker:allow every person that can measure their
Speaker:blood, glucose, and ketones with a meter,
Speaker:either by pricking their finger to get a
Speaker:drop of blood or using a continuous
Speaker:glucose ketone monitor on your cell
Speaker:phone, you will be able to know when you
Speaker:apply the GKI index, you will know
Speaker:exactly what zone of
Speaker:health you are in or not in.
Speaker:So you can know that you will be in a
Speaker:high risk red zone if you have a GKI
Speaker:that's over 50, up to 100.
Speaker:You are going to be in a zone of
Speaker:mitochondrial ill health.
Speaker:Can we backtrack quickly, Dr.
Speaker:Seifried?
Speaker:Sorry about that.
Speaker:Just briefly discuss what the glucose
Speaker:ketone index is, just for those in the
Speaker:audience who maybe
Speaker:aren't familiar with it.
Speaker:Obviously, it's a biomarker that I know
Speaker:you have been intimately
Speaker:involved in developing.
Speaker:But what exactly is this
Speaker:index and then how does it work?
Speaker:Obviously, we are monitoring two
Speaker:different biomarkers here, ketones,
Speaker:things like butyl
Speaker:hydroxybutyrate, acetate, etc.
Speaker:And then obviously glucose.
Speaker:But how does looking at those two markers
Speaker:from a metabolic health standpoint help
Speaker:us to, well, a, determine metabolic
Speaker:health and maybe just a
Speaker:bit more nuance there.
Speaker:I know there's
Speaker:generally a range there as well.
Speaker:I think you want to aim for about a three
Speaker:when looking to try and deal
Speaker:with things therapeutically.
Speaker:I may be wrong there.
Speaker:But yeah, if you could just fill us in
Speaker:sort of very fiduciary on
Speaker:what that index is all about.
Speaker:So again, go back to
Speaker:evolutionary biology.
Speaker:Paleolithic man was always in a state of
Speaker:nutritional ketosis, mainly because they
Speaker:did not have access to highly processed
Speaker:carbohydrates in their diet.
Speaker:So they had a lot of exercise and they
Speaker:had a diet that was largely carnivorous
Speaker:with some vegetables, some
Speaker:tubers and this kind of thing.
Speaker:But they were complex carbs.
Speaker:They weren't these highly processed, like
Speaker:you mentioned already, highly glycemic
Speaker:index kinds of things.
Speaker:And food was limited.
Speaker:So when you put that body and you look at
Speaker:the, if they could look at their glucose
Speaker:and ketones at that stage, they would
Speaker:find themselves in a state of nutritional
Speaker:ketosis, which is an elevation of ketone
Speaker:bodies and a very low glucose level, or I
Speaker:should say very normal, like 65 to 85
Speaker:milligram per deciliter, maybe
Speaker:a 3.2 to 4 millimolar glucose.
Speaker:These are normal body levels of glucose
Speaker:produced by the combination of
Speaker:gluconeogenesis as well as carbohydrates
Speaker:that we would get from the diet.
Speaker:So we would always be in this beautiful
Speaker:insulin, super insulin sensitive zone, no
Speaker:insulin resistance at all, because
Speaker:diabetes would be unheard of, type two,
Speaker:of course, not type one.
Speaker:Type one would have been afflicting us
Speaker:from the beginning of
Speaker:time in one way or another.
Speaker:But our bodies would have been in
Speaker:metabolic homeostasis as long as we
Speaker:weren't starving, of course.
Speaker:But we could go long periods of time
Speaker:without eating and still maintain
Speaker:metabolic homeostasis because we would be
Speaker:burning ketone bodies that would be
Speaker:mobilized from stored fat.
Speaker:So we developed the glucose ketone index
Speaker:as a marker, biomarker, to allow us to
Speaker:know what level of metabolic
Speaker:homeostasis we would be in.
Speaker:So if you have a glucose ketone index of
Speaker:20 or 10, I mean, you're in some level of
Speaker:metabolic homeostasis.
Speaker:If you want to go into a deeper level of
Speaker:what we call therapeutic ketosis, then
Speaker:you'd go down to a level of two, which is
Speaker:the ratio of blood sugar divided by the
Speaker:ratio of beta hydroxybutyrate, which is
Speaker:the main ketone body.
Speaker:And then you would say,
Speaker:oh, how do we know this?
Speaker:Because I have friends, Dom DiAgostino,
Speaker:Anthony Chapp in these guys, they're
Speaker:always in these states
Speaker:of nutritional ketosis.
Speaker:What do they do?
Speaker:They do a lot of exercise
Speaker:and they eat a lot of meat.
Speaker:And they stay in these
Speaker:paleolithic kinds of zones.
Speaker:And these are the zones that keep your
Speaker:mitochondria super healthy.
Speaker:So what we do is we take people from the
Speaker:population and look at guys that have
Speaker:type 2 diabetes,
Speaker:obesity, and all these things.
Speaker:And you find these GKI values over 50,
Speaker:100, sometimes above 100.
Speaker:Are you kidding me?
Speaker:I mean, it should be down in
Speaker:the 5 to 10 zone or 20 zone.
Speaker:And you've got 200?
Speaker:Oh, I'm obese.
Speaker:I got systemic inflammation.
Speaker:I got to, of course, you're not in
Speaker:metabolic homeostasis.
Speaker:So the glucose ketone index tells us I
Speaker:built it for the cancer patients, because
Speaker:we knew that if we lowered blood sugar
Speaker:down far enough, the tumor cells need the
Speaker:sugar to grow, and they
Speaker:can't switch to ketones.
Speaker:So you put them in a
Speaker:very compromised condition.
Speaker:Now, what we do is we see cancer
Speaker:shrinking down tremendously when you get
Speaker:the GKI 2.0 or below,
Speaker:but you still have the glutamine issue.
Speaker:So then we develop the pulse therapy to
Speaker:come in and target with low dose of
Speaker:glutamine inhibitors while the person is
Speaker:in a state of nutritional ketosis.
Speaker:And glutamine being the fermentable amino
Speaker:acid that is then utilized as an
Speaker:alternative fuel source by various
Speaker:cancers in the absence
Speaker:of glucose is accurate.
Speaker:Yeah.
Speaker:And people always ask me, what can you do
Speaker:to lower, what diet can
Speaker:I use to lower glutamine?
Speaker:And if I eat meat,
Speaker:won't that raise glutamine?
Speaker:The glutamine in our body is already
Speaker:super saturated because we use it for so
Speaker:many things, the gut
Speaker:and our immune system.
Speaker:We already have more than enough
Speaker:glutamine circulating in the body to
Speaker:provide a tumor cell with more than
Speaker:enough fuel in that regard.
Speaker:So there's no diet that will lower
Speaker:glucose, correction glutamine.
Speaker:And the glutamine will always be there.
Speaker:So you can't, even if you do exercise,
Speaker:yes, you can lower glutamine, but it's
Speaker:not to the level where you're going to
Speaker:kill the tumor cell.
Speaker:So that's why we need drugs.
Speaker:But the drugs have to be strategic.
Speaker:While you're in nutritional ketosis,
Speaker:blood sugar is down,
Speaker:ketones are elevated.
Speaker:So you got a choke hold
Speaker:on the glucose pathway.
Speaker:But you got the
Speaker:glutamine pathway still opened.
Speaker:And then we come in with specific drugs
Speaker:that will block glutamine's availability.
Speaker:But we have to do this very strategically
Speaker:because the same fuel is
Speaker:needed by our immune cells.
Speaker:Our immune cells and our gut use the same
Speaker:fuel the tumor cells are using.
Speaker:So that's why we
Speaker:developed the press pulse.
Speaker:So we pulse glutamine.
Speaker:We do pulsing of glutamine targeting,
Speaker:killing tumor cells over a short period
Speaker:of time, removing the pulse, and allowing
Speaker:the immune system to come in and kill, to
Speaker:pick up the dead corpses.
Speaker:So you have to have the undertakers
Speaker:coming in and get rid of the dead bodies
Speaker:in the microenvironment.
Speaker:And that's your immune system.
Speaker:And they need glutamine as well.
Speaker:So this is why you need to understand
Speaker:evolutionary biology and biochemistry to
Speaker:effectively manage cancer.
Speaker:If you don't understand biology and
Speaker:biochemistry and evolutionary biology,
Speaker:you are still in the stone age when it
Speaker:comes to this kind of stuff.
Speaker:You're just peddling drugs and hoping for
Speaker:the best case scenario.
Speaker:Yes.
Speaker:You don't know why things
Speaker:are working or how they work.
Speaker:We know exactly how things
Speaker:are working and why they work.
Speaker:And we try to perfect the system to keep
Speaker:these tumor cells under
Speaker:restricted fuel conditions.
Speaker:And the body itself, when increased in
Speaker:its health, will turn on the tumor cell,
Speaker:on the tumor cells,
Speaker:and use them for fuel.
Speaker:It's called autolytic cannibalism.
Speaker:So the body itself, when put under energy
Speaker:restriction, every cell in the body must
Speaker:earn its existence in that body.
Speaker:There can be no weak, lame, inefficient
Speaker:cells because the body will turn on them
Speaker:and use them for fuel.
Speaker:The tumor itself becomes a fuel source
Speaker:for the rest of the body when you're put
Speaker:into these states of nutritional ketosis.
Speaker:So part of the solution to the problem is
Speaker:when the normal cells recognize a
Speaker:population of cells that are inefficient
Speaker:in utilization of energy.
Speaker:And they turn on them and dissolve them
Speaker:and use them for fuel.
Speaker:And people say, "I don't know what
Speaker:happened to my tumor.
Speaker:It just kind of disappeared when I was in
Speaker:nutritional ketosis."
Speaker:Well, you're damn body-ated.
Speaker:Because it was inefficient.
Speaker:They were using energy inefficiently.
Speaker:And the body recognizes that.
Speaker:And this is the term
Speaker:autolytic cannibalism.
Speaker:I published that.
Speaker:But we also can strategically target
Speaker:glutamine to work together.
Speaker:It's a whole systems approach to
Speaker:eliminating a bunch of cells that are
Speaker:growing out of control, using energy very
Speaker:inefficiently, being dependent
Speaker:predominantly on glucose and glutamine,
Speaker:and not being able to
Speaker:burn fatty acids or ketones.
Speaker:It's an elegant system.
Speaker:It's so beautiful.
Speaker:It works for the majority of people.
Speaker:And nobody's doing this.
Speaker:There's no clinical
Speaker:trial anywhere on the planet.
Speaker:Don't make much money out of it, can you?
Speaker:Well, the money issue
Speaker:now becomes another issue.
Speaker:It's revenue first,
Speaker:patient outcome second.
Speaker:And I think people need to know that.
Speaker:They should know that their disease is
Speaker:supporting a giant industry.
Speaker:Many people are grateful
Speaker:for those who have cancer.
Speaker:Because the cancer patient supports a
Speaker:very lucrative process that would be
Speaker:potentially disturbed if we were to find
Speaker:a method or a way to prevent
Speaker:or manage cancer effectively.
Speaker:But man has made adjustments and
Speaker:adaptations to disruptive technologies.
Speaker:And they will do the same with this
Speaker:cancer and chronic disease situation.
Speaker:It's just a matter of time.
Speaker:Because we cannot continue on this path
Speaker:of this abysmal path that we've been on
Speaker:for the last 75, 100 years.
Speaker:So we will begin to change.
Speaker:But there will be new industries and new
Speaker:strategies for exploring
Speaker:and keeping people healthy.
Speaker:And others, so we're trying to get a
Speaker:revenue transition of revenue generation
Speaker:from one failed system to a system that
Speaker:really works but has not yet been mature
Speaker:to replace the revenue
Speaker:lost from one system.
Speaker:But I think that's all
Speaker:part of the future as well.
Speaker:But right now, my job is just to keep
Speaker:people alive with a higher quality of
Speaker:life, using the knowledge of the biology
Speaker:and biochemistry of the
Speaker:disease that we understand.
Speaker:Yeah.
Speaker:Now that's fascinating.
Speaker:And I definitely would love to come back
Speaker:to that in a minute.
Speaker:I'd just like to quickly chat about the
Speaker:ketogenic diet a bit more.
Speaker:And I'm going to ask my question first
Speaker:and then Ramblom from a group of mine.
Speaker:I have a few concerns about sort of long
Speaker:term utilization of the ketogenic diet,
Speaker:not for everybody, but just I have found
Speaker:that there are various people who do
Speaker:follow a ketogenic diet, obviously are
Speaker:going to run into certain problems, some
Speaker:of them endocrine in nature, etc.
Speaker:Now, I think of course, most people who
Speaker:are going to explore this meta,
Speaker:who are going to explore cancer treatment
Speaker:from a metabolic standpoint, are going to
Speaker:utilize a ketogenic diet as their first
Speaker:step and why should they not?
Speaker:Now, as I mentioned, I've
Speaker:got a few sort of concerns.
Speaker:For example, I believe there's rodent
Speaker:data out there to show that ketogenic
Speaker:diets long term may impair, I think it's
Speaker:hepatic FGF21 signaling due to receptor
Speaker:downregulation and that there are other
Speaker:drivers issues there as well.
Speaker:For example, peripheral insulin
Speaker:resistance, which I'm sure you're
Speaker:familiar with for the audience listening,
Speaker:that being the idea that in some people
Speaker:long term ketogenic diet,
Speaker:adherence can essentially cause an
Speaker:insulin resistant like state at the level
Speaker:of the muscle because the body is sort of
Speaker:not able or not readily utilizing the
Speaker:glucose at its disposal effectively.
Speaker:Now, I'm just some second here, but I
Speaker:would be at least mechanistically
Speaker:concerned that those high levels of
Speaker:glucose might then also be a contributing
Speaker:factor if you're sort of becoming more
Speaker:and more insulin resistant.
Speaker:So, the way I see it, just from the GKI
Speaker:score side of things, and again, this is
Speaker:just me piecing a few things together, so
Speaker:tell me where I'm wrong, but are there
Speaker:other ways that you can sort of look at
Speaker:increasing your GKI score
Speaker:maybe without necessarily
Speaker:utilizing long term ketosis?
Speaker:And I suppose that's
Speaker:a question in itself.
Speaker:Should we always be in a state of ketosis
Speaker:or should we sort of keep it for a period
Speaker:of time, such as when, hopefully not, you
Speaker:have a disease like
Speaker:this where it's needed?
Speaker:But beyond that, what about strategies
Speaker:where you are either intermittently
Speaker:fasting and obviously including a certain
Speaker:amount of carbohydrates
Speaker:in that eating window?
Speaker:Would that fasting period, obviously
Speaker:again, the lower glycemic things, not
Speaker:talking about swallowing large quantities
Speaker:of honey and processed sugar,
Speaker:and then, yeah, other fuel sources maybe
Speaker:that can sort of increase ketone
Speaker:production, your ketone
Speaker:esters, your NCT oils,
Speaker:yeah, again, I hope that makes sense.
Speaker:I am rambling a bit and as you've no
Speaker:doubt already figured out, I'm definitely
Speaker:outside more with your house here.
Speaker:But are there, do you have any concerns
Speaker:again for the average person following a
Speaker:ketogenic for a longer period of time,
Speaker:perhaps in light of those
Speaker:mechanisms that I mentioned?
Speaker:And then beyond that, are those other
Speaker:strategies aimed at sort of improving a
Speaker:GKI index maybe without being in a
Speaker:constant state of ketosis, are they worth
Speaker:exploring or is it just not enough to
Speaker:actually deal with the matter at hand?
Speaker:Yeah, well, you got a lot of stuff that
Speaker:you just threw at me right there.
Speaker:Yeah, sorry about that.
Speaker:But we can break it down.
Speaker:But you're 100% correct.
Speaker:There's a lot of people who use ketogenic
Speaker:diets inappropriately that are not
Speaker:balanced with micro and macro nutrients,
Speaker:which then can lead to some of the
Speaker:conditions that you mentioned in your
Speaker:rambling.
Speaker:Yeah, in your ramblings.
Speaker:But I have seen the same thing.
Speaker:I mean, when we fed
Speaker:ketogenic diets to the mice,
Speaker:or humans, in an unrestricted way, diets
Speaker:that were not completely balanced in
Speaker:micro and macro nutrients,
Speaker:we got all of many of the health issues
Speaker:that you mentioned were seen.
Speaker:The tumors actually grew faster.
Speaker:There was a complete
Speaker:metabolic in homeostasis.
Speaker:You found conditions that would be
Speaker:reflective of some of
Speaker:what you have mentioned.
Speaker:That's why we try to get
Speaker:away from the term diet.
Speaker:And we talk about nutritional ketosis as
Speaker:a state of metabolic homeostasis, where
Speaker:your levels of ketones are not
Speaker:exorbitantly high, and your levels of
Speaker:glucose are not exorbitantly low.
Speaker:But you are balanced in micro and macro
Speaker:nutrients with a GKI of five or 10.
Speaker:And exactly as you said, in our new paper
Speaker:that we're working on right now, which
Speaker:will revolutionize the treatment of
Speaker:cancer and all these chronic diseases,
Speaker:we have built a color-coded chart to
Speaker:allow people to know what zones they're
Speaker:in at any given time, and whether or not
Speaker:they can move effectively
Speaker:from one zone to the next.
Speaker:Like, yes, intermittent fasting.
Speaker:Or the enjoyment, if you have been in a
Speaker:state of nutritional ketosis and you go
Speaker:out and party, and your body then shows a
Speaker:much higher GKI,
Speaker:which would be unhealthy,
Speaker:you would then know what you would need
Speaker:to do to bring it back into a normal
Speaker:range with the types of foods and
Speaker:exercise is extremely important.
Speaker:You can move these zones up and down.
Speaker:So you don't have to feel compelled to be
Speaker:locked into a particular state.
Speaker:But having the knowledge of what are the
Speaker:healthy states and what aren't the
Speaker:healthy states, knowing, like for
Speaker:example, the Greek patients that did
Speaker:really well on the keto diet, it was a
Speaker:calorie-restricted Mediterranean diet.
Speaker:Sardines, salmon, avocados, olive oil,
Speaker:and this kind of thing that most people
Speaker:can do without too much difficulty.
Speaker:They had good GKI.
Speaker:They were very balanced in
Speaker:micro and macro nutrients.
Speaker:But you could switch
Speaker:from that to a carnivore.
Speaker:There's a lot of flexibility in what a
Speaker:person can do to move in and out of these
Speaker:health zones without
Speaker:causing metabolic in-homeostasis.
Speaker:So we're working on that.
Speaker:We've published a big paper for the brain
Speaker:cancer patients to tell them exactly and
Speaker:address the questions that you raised.
Speaker:What are the choices?
Speaker:What are the variations that you can use
Speaker:to maintain constant pressure on tumor
Speaker:cells while constantly keeping the
Speaker:homeostasis of your normal cells at the
Speaker:highest level and metabolic homeostasis?
Speaker:So we're working on that.
Speaker:And to address your questions, most of
Speaker:the health problems associated with
Speaker:long-term ketogenic diets result from
Speaker:micro and macro nutrient imbalances that
Speaker:lead to pathologies, some of which you
Speaker:have already elucidated.
Speaker:So once the base of knowledge becomes
Speaker:available for people,
Speaker:they can then build diets.
Speaker:And we call it nutritional ketosis,
Speaker:because you can achieve that with a
Speaker:carnivore diet, a
Speaker:Mediterranean diet, a pescatarian diet.
Speaker:Vegan diets are a little harder.
Speaker:A veganism, you have to supplement with
Speaker:micronutrients and some macronutrients in
Speaker:order to maintain metabolic home.
Speaker:It's not a natural situation.
Speaker:Humans did not evolve as vegans.
Speaker:If we were vegans, we would have been
Speaker:extinct a long time ago.
Speaker:But we are omnivores.
Speaker:Our bodies were evolved to eat anything,
Speaker:walks, crawls, flies,
Speaker:or swims on this planet.
Speaker:And you can build nutritional ketosis
Speaker:from combinations of the natural foods
Speaker:that we evolved to eat.
Speaker:You just have to adjust the amounts that
Speaker:you're eating and the
Speaker:types that you're eating.
Speaker:So in our new study that will come out
Speaker:for managing cancer and chronic diseases,
Speaker:deals exactly with what you have
Speaker:mentioned, to allow people to always
Speaker:remain in a state of maximal metabolic
Speaker:homeostasis, but allowing the individual
Speaker:to know what zone of health they're in to
Speaker:allow mitochondria to be as healthy as
Speaker:possible, and not too restrictive in
Speaker:rigidity in what you're doing.
Speaker:Because part of enjoyment of life is the enjoyment of what we
Speaker:like to eat and drink.
Speaker:And we don't like to be pigeonholed into
Speaker:a particular way of doing something that
Speaker:eventually turns someone
Speaker:from being happy into miserable.
Speaker:But now with our new system that will
Speaker:come out on the apps, you will know at
Speaker:any given time what you can eat, for how
Speaker:long, and how healthy it can be.
Speaker:So everybody will, and
Speaker:everybody's unique individual.
Speaker:We also have to recognize that we have
Speaker:sex differences, we have age differences,
Speaker:we have cultural differences, and we have
Speaker:religious differences.
Speaker:So people are in these cultural,
Speaker:religion, different ages and things.
Speaker:They have to build their diet and
Speaker:lifestyle around a GKI that meets their
Speaker:needs and keeps them
Speaker:in a comfortable zone.
Speaker:And they'll know the quantification of
Speaker:that by looking at their glucose ketone
Speaker:index and matching it to a
Speaker:particular zone of health.
Speaker:So we will eliminate adverse effects,
Speaker:allowing people to be flexible so they
Speaker:can prevent these kinds of situations.
Speaker:And I think what we're running into now
Speaker:is people say, "Oh, I'm doing a keto, I'm
Speaker:eating lard every day, and I'm getting
Speaker:unhealthy and I'm getting unhealthy."
Speaker:Yeah, who wouldn't get unhealthy?
Speaker:The question is, we want to eliminate
Speaker:those kinds of ambiguities in what people
Speaker:can and cannot eat and give them the
Speaker:level of flexibility that will make it
Speaker:comfortable for their existence while at
Speaker:the same time
Speaker:maintaining mitochondrial health.
Speaker:And I think knowledge is power and every
Speaker:individual will adjust their own GKI and
Speaker:build their own diets and know how much
Speaker:exercise they need to do and to keep
Speaker:their body in a state of
Speaker:nutritional and physical health.
Speaker:So this is the future.
Speaker:But we're aware of everything you said.
Speaker:And when you start something off in the
Speaker:beginning, people sometimes overdo it,
Speaker:they do it the wrong way.
Speaker:And then they end up with these
Speaker:pathologies that become apparent for,
Speaker:like you mentioned, with all these...
Speaker:Our registry, sex, home industries.
Speaker:Yeah, I mean, that
Speaker:should not have to happen.
Speaker:Paleolithic man never had
Speaker:to deal with these things.
Speaker:His main problem was starvation.
Speaker:When you don't have any
Speaker:food, you starve to death.
Speaker:Well, you can only get ketones if you
Speaker:have hormonal insulin levels.
Speaker:Your ketones can never get ketoacidotic.
Speaker:That's type 1 diabetes predominantly
Speaker:where you have very high glucose and very
Speaker:high ketones together in your body.
Speaker:That's pathological.
Speaker:Natural therapeutic ketosis is low
Speaker:glucose elevated ketones, but not
Speaker:elevated to the level of ketoacid because
Speaker:you piss out excess ketones.
Speaker:But when you don't have insulin, you keep
Speaker:all that in your body.
Speaker:Your body seems like a starving.
Speaker:You can't get rid of the...
Speaker:You're making ketones and too high of a
Speaker:level, keeping too much in your body.
Speaker:So again, and we also know that there are
Speaker:some people that have carnitine
Speaker:deficiencies that
Speaker:can't metabolize ketones.
Speaker:There are people that get severe rashes
Speaker:from trying to get into these conditions.
Speaker:And there's certain people take
Speaker:medications that interfere with the
Speaker:ability to metabolize ketone bodies.
Speaker:So we have to be aware of the
Speaker:interference of nutritional ketosis.
Speaker:But at least when you're aware, you can
Speaker:alert people to these hazards, metabolic
Speaker:hazards, and they can
Speaker:make adjustments themselves.
Speaker:So all of this, we have
Speaker:thought about all of this.
Speaker:Why?
Speaker:Because we don't do anything else in our
Speaker:life except think about
Speaker:these kinds of things.
Speaker:We're laser focused.
Speaker:We don't think about anything else except
Speaker:what you just talked about.
Speaker:Not just occasionally, 24 seven.
Speaker:That's what we do.
Speaker:Dr.
Speaker:Seifried, thank you so much for that.
Speaker:That was incredible.
Speaker:To be honest, I think I've got through
Speaker:what, 20% of the questions that I'd hoped
Speaker:to be able to talk to you about today.
Speaker:So I'm going to have to twist your arm
Speaker:somehow, God willing, and to get me back
Speaker:from at some point in the future.
Speaker:What was your main
Speaker:question that I did not answer?
Speaker:Oh, no.
Speaker:I wanted to go down the rabbit hole
Speaker:regarding various fatty acids and
Speaker:specifically talk about saturated fats
Speaker:versus unsaturated fats and the issues
Speaker:regarding some people running into
Speaker:insulin resistance, having sort of high
Speaker:amounts of saturated
Speaker:fats in the ceramides.
Speaker:I don't know if you've
Speaker:seen that to be an issue.
Speaker:We published a big paper looking at all
Speaker:that stuff in mice,
Speaker:unrestricted and unrestricted.
Speaker:It's hard to get into ketosis on
Speaker:polyunsaturated fatty acids,
Speaker:but they're, the omega three fatty acids
Speaker:are very healthy for people.
Speaker:Some of the omega sixes are not.
Speaker:So we published a big paper on all this.
Speaker:So almost everything I have looked at in
Speaker:one way or the other, I just don't have
Speaker:time to talk about it at all, but our
Speaker:open access papers on restricted and
Speaker:unrestricted diets, high carb keto and
Speaker:fish oil diets and
Speaker:all this kind of stuff.
Speaker:So we have looked at that and the body is
Speaker:a machine that
Speaker:metabolizes the fuels effectively.
Speaker:Ketones will be
Speaker:produced from saturated fat.
Speaker:MCT oil, little MCT oil, is really great
Speaker:in producing ketone bodies endogenously.
Speaker:D beta hydroxybutyrate rather than L's.
Speaker:There's a way to do all that.
Speaker:We've looked at almost
Speaker:every damn thing we can look at.
Speaker:So I have papers on that, but yes, we
Speaker:have looked at that.
Speaker:We try to do everything, always remember,
Speaker:everything is metabolized majority in the
Speaker:mitochondria, the cytoplasm.
Speaker:So once you understand these metabolic
Speaker:pathways, you know how to keep your
Speaker:mitochondria as healthy as possible,
Speaker:which will make you, because ultimately
Speaker:you're interested in
Speaker:avoiding chronic disease.
Speaker:That's it.
Speaker:You don't want chronic disease.
Speaker:You don't want cancer.
Speaker:You don't want chronic disease.
Speaker:How do you prevent that?
Speaker:Keep your mitochondria healthy.
Speaker:How do you keep your
Speaker:mitochondria healthy?
Speaker:Keep glucose down and
Speaker:elevate ketones, the mitochondria.
Speaker:And I don't have time to talk, but in our
Speaker:new paper, we talk about the
Speaker:bioenergetics of burning fatty acids,
Speaker:ketone bodies, and pyruvate.
Speaker:The bioenergetic related to the delta G
Speaker:prime ATP hydrolysis.
Speaker:And how we can get
Speaker:more bang for your buck.
Speaker:Every breath of air can give you more ATP
Speaker:when you're burning ketone body than when
Speaker:you're burning pyruvate or fatty acids.
Speaker:So we know the bioenergetics.
Speaker:We published that.
Speaker:And our big paper is going
Speaker:to be coming out on that.
Speaker:And we got all that from the late Richard
Speaker:Veach, one of the great, and he was Hans
Speaker:Krebs' last graduate student.
Speaker:So he and I would talk for hours and
Speaker:hours and hours about all the
Speaker:bioenergetics of mitochondria and what
Speaker:you need to keep it
Speaker:healthy and functional.
Speaker:So there's a strong bioenergetic
Speaker:explanation for a lot of what I'm saying.
Speaker:And that's in our papers.
Speaker:We'll definitely be sure to
Speaker:link them in all the show.
Speaker:Yeah.
Speaker:Make sure, yeah.
Speaker:Tell folks that all of
Speaker:our papers are open access.
Speaker:So anybody with a
Speaker:computer can get the information.
Speaker:Now people are going to be overwhelmed
Speaker:and say, oh my God,
Speaker:Seifree published so many papers.
Speaker:Yeah.
Speaker:Well, a lot of it's on
Speaker:what I'm talking about.
Speaker:A lot of it's on other things.
Speaker:But you can go through and
Speaker:ferret out what we're doing.
Speaker:And people need to know that all of our
Speaker:research is supported by philanthropy and
Speaker:private foundations.
Speaker:So when we keep people
Speaker:alive who are stage four cancer,
Speaker:they so-called terminal.
Speaker:And all of a sudden you're living a lot
Speaker:longer with a higher quality of life.
Speaker:Some people feel very compelled to donate
Speaker:to our research because they
Speaker:want to.
Speaker:And one thing I want to make sure, never
Speaker:say we have a cure for cancer.
Speaker:Because I have no clue whether what we do
Speaker:will cure cancer or not.
Speaker:The only thing that we have seen over and
Speaker:over again is we have a longer
Speaker:progression-free survival without
Speaker:symptoms and a very increased overall
Speaker:survival of cancer patients.
Speaker:Whether they're cured
Speaker:or not, we don't know.
Speaker:But I consider success in keeping people
Speaker:given terminal diagnosis alive far, far
Speaker:longer than what the establishment
Speaker:predicted their lifespan to be.
Speaker:So I never like to use the term terminal
Speaker:because I have a lot of people that I
Speaker:know who are still alive.
Speaker:I don't know.
Speaker:Sometime in the future they may be
Speaker:terminal, but they're not dead yet and
Speaker:they're pretty healthy.
Speaker:So what the hell does that mean?
Speaker:And they were told they only had nine
Speaker:months to live and
Speaker:they're around six years.
Speaker:Who made the mistake there?
Speaker:Why was someone told they have six months
Speaker:or a year to live and they're living five
Speaker:and six years or even longer?
Speaker:How did anybody make
Speaker:that level of mistake?
Speaker:They made the mistake because they don't
Speaker:understand metabolic therapy and how long
Speaker:you can possibly live with
Speaker:a higher quality of life.
Speaker:But whether you get a
Speaker:cure or not, I have no clue.
Speaker:All we know is we have a new strategy for
Speaker:managing cancer and chronic disease that
Speaker:is far more powerful and successful than
Speaker:anything out there right now.
Speaker:The problem is people just don't know
Speaker:about it and don't know
Speaker:how to implement it yet.
Speaker:And that's going to take
Speaker:that will be the future.
Speaker:That will be down to people like us,
Speaker:aiming to educate the greater public.
Speaker:Dr.
Speaker:Seifried, thank you
Speaker:so much for your time.
Speaker:For people who are interested in your
Speaker:work and to learn more about your various
Speaker:metabolic therapies,
Speaker:where can we point them to?
Speaker:Well again, I have my metabolic papers
Speaker:already published, open access.
Speaker:And donations go to Travis
Speaker:Christofferson's Foundation
Speaker:for Cancer Metabolic Therapy.
Speaker:It's a legitimate foundation.
Speaker:And the university, Boston College
Speaker:itself, the biology department for sure.
Speaker:So that keeps us going and we've got a
Speaker:couple of blockbuster things coming out
Speaker:that are really going to transform the
Speaker:healthcare industry dramatically.
Speaker:And they'll be out within the year.
Speaker:And then you're going to see
Speaker:organizations set up around these
Speaker:approaches for metabolic health.
Speaker:And we're going to bring a lot of people
Speaker:back into what we call normalcy,
Speaker:metabolic homeostasis, if they want to.
Speaker:I'm not twisting anybody's arm here.
Speaker:It's only if people who want to, if they
Speaker:want to live in a toxic
Speaker:state, that's their choice.
Speaker:But we have a tool now to allow them to
Speaker:come out of those toxic states and live a
Speaker:healthy, productive life with a clear
Speaker:quantitative assessment to do that.
Speaker:And that is coming down and you'll see
Speaker:that within the next
Speaker:year or two, for sure.
Speaker:So we're very hopeful for
Speaker:managing chronic diseases.
Speaker:And I think most people are going to be
Speaker:very appreciative as they begin to
Speaker:benefit from what we're doing.
Speaker:No, I'm sure they're well.
Speaker:I mean, ultimately, I think most disease,
Speaker:the way I'm starting to view it, it
Speaker:ultimately comes down to sort of removing
Speaker:the environmental burden or whatever
Speaker:environmental trigger there is as driving
Speaker:the disease, improving the metabolic
Speaker:health and subsequent treatment,
Speaker:mitochondrial health, and then dealing
Speaker:with the stress component, which is also
Speaker:obviously overlooked.
Speaker:And I think when you get those three sort
Speaker:of components sort of dialed in, you sort
Speaker:of solve 90% of the equation, at least
Speaker:when it comes to chronic disease.
Speaker:Which is mostly
Speaker:crippling Western societies.
Speaker:Yes.
Speaker:So it's the single most biggest problem.
Speaker:Cancer and chronic diseases are dementia,
Speaker:type 2 diabetes, obesity,
Speaker:cardiovascular disease, cancer.
Speaker:You can go right down the list.
Speaker:It's just like everything.
Speaker:So what do we do with all these healthy
Speaker:people if they will...
Speaker:We're keeping a lot of people alive,
Speaker:working for a longer period of time with
Speaker:a high quality of life.
Speaker:I mean, you're going to have to have a
Speaker:readjustment of society.
Speaker:Yeah.
Speaker:Well, let's aim to get there and then we
Speaker:can do what that problem arises.
Speaker:Yes, absolutely.
Speaker:All right.
Speaker:Well, listen, thank you very much.
Speaker:Thank you, Dr.
Speaker:Seifried.
Speaker:It's been an absolute honor and I
Speaker:appreciate your time.
Speaker:Yeah.
Speaker:Well, thank you. I'll